載入...

Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study

Anaplastic thyroid cancer (ATC) is associated with an extremely poor prognosis and is resistant to the majority of chemotherapies. In 2015, lenvatinib was approved for treating ATC in Japan. The present study aimed to evaluate the overall survival (OS) of patients with ATC treated with lenvatinib. A...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncol Lett
Main Authors: Iwasaki, Hiroyuki, Yamazaki, Haruhiko, Takasaki, Hirotaka, Suganuma, Nobuyasu, Nakayama, Hirotaka, Toda, Soji, Masudo, Katsuhiko
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256365/
https://ncbi.nlm.nih.gov/pubmed/30546466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9553
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!